4D Molecular Therapeutics FDMT
NASDAQ FDMT
$13.67 -0.17 (-1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Cash & Current Investments (2019 - 2026)

Updated

4D Molecular Therapeutics (FDMT) posted Cash & Current Investments of $361.33 million for Q2 2026, up 23.2% from $293.23 million a year earlier but down 7.6% from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, 4D Molecular Therapeutics' Cash & Current Investments came in at $402.66 million, down 5.2% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In prior years, 4D Molecular Therapeutics' Cash & Current Investments was $424.88 million in FY2024 (+47.4%), $288.23 million in FY2023 (+35.0%), $213.55 million in FY2022 (-13.8%) and $247.78 million in FY2021 (-10.5%).
  • Quarterly Cash & Current Investments has run from a low of $161.68 million in Q3 2021 to a high of $541.95 million in Q2 2024 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in four of the last eight quarters, with growth averaging 2.5%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2024, with growth of 162.4%; the weakest was Q2 2025, with a decline of 45.9%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $390.89 million (Q1 2026), $402.66 million (Q4 2025) and $305.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 4D Molecular Therapeutics 960.62 Mn -499.33 Mn - 361.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 361.33 Mn
Mar 31, 2026 390.89 Mn
Dec 31, 2025 402.66 Mn
Sep 30, 2025 305.06 Mn
Jun 30, 2025 293.23 Mn
Mar 31, 2025 321.44 Mn
Dec 31, 2024 424.88 Mn
Sep 30, 2024 501.89 Mn
Jun 30, 2024 541.95 Mn
Mar 31, 2024 525.91 Mn
Dec 31, 2023 288.23 Mn
Sep 30, 2023 319.66 Mn
Jun 30, 2023 310.34 Mn
Mar 31, 2023 200.45 Mn
Dec 31, 2022 213.55 Mn
Sep 30, 2022 227.72 Mn
Jun 30, 2022 241.09 Mn
Mar 31, 2022 236.15 Mn
Dec 31, 2021 247.78 Mn
Sep 30, 2021 161.68 Mn
API Access

4D Molecular Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FDMT&period=max&api_key=YOUR_API_KEY